Fundraising Fox
Carthera
Lyon, FR · Founded 2010 · 35 employees on LinkedIn · 4 known investors
Find your way into Carthera
Carthera develops SonoCloud®, an implantable ultrasound device that temporarily disrupts the blood-brain barrier to improve drug delivery to the brain for treatment of brain diseases including glioblastoma, brain metastases, and Alzheimer's Disease. The company's technology uses low-intensity pulsed ultrasound combined with microbubbles to increase therapeutic efficacy of existing and new therapies.
Founders & leadership
Carthera was founded in 2010 by Alexandre Carpentier.
Investors · 4
Supernova Investlisted by Supernova InvestParis
How we know: the VCSheet dataset · Not right? Tell us
Funding
SEC filings, press & company announcementsSource: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Carthera do?
- Carthera develops SonoCloud®, an implantable ultrasound device that temporarily disrupts the blood-brain barrier to improve drug delivery to the brain for treatment of brain diseases including glioblastoma, brain metastases, and Alzheimer's Disease. The company's technology uses low-intensity pulsed ultrasound combined with microbubbles to increase therapeutic efficacy of existing and new therapies.
- Who founded Carthera?
- Carthera was founded by Alexandre Carpentier in 2010.
- Who are Carthera's investors?
- Carthera's investors include Supernova, Agoranov, Supernova Invest, Unorthodox Ventures.
- Where is Carthera headquartered?
- Carthera is headquartered in Lyon, FR.